Downregulation of NKG2DLs by TGF-β in Human Lung Cancer Cells

By
Justin.choi
-
0
148
Scientists examined the expression of NKG2DLs, PD-L1 and PD-L2 in lung cancer cells after treatment of TGF-β and a TGF-β inhibitor, Galunisertib.
[BMC Immunology]

Sorry, but the selected Zotpress account can't be found.

Full Article